Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard treatment regimens

OBJECTIVE: This study aimed to evaluate the efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization (DEB-TACE) versus regorafenib monotherapy in colorectal cancer liver metastases (CRLM) patients who failed standard treatment regimens. METHODS: Totally, 76 eligible...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Fei, Zheng, Jiaping, Luo, Jun, Zhang, Zhewei, Shao, Guoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397621/
https://www.ncbi.nlm.nih.gov/pubmed/34302208
http://dx.doi.org/10.1007/s00432-021-03708-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397621/
https://www.ncbi.nlm.nih.gov/pubmed/34302208
http://dx.doi.org/10.1007/s00432-021-03708-1

Ejemplares similares